409 filings
Page 20 of 21
8-K
pxhe teu3mb6uu5f
21 Feb 07
Departure of Directors or Principal Officers
12:00am
8-K
4znv656 s11tonf
20 Feb 07
Other Events
12:00am
8-K
38ou6m
8 Feb 07
Results of Operations and Financial Condition
12:00am
8-K
jgqw76 uqw
8 Dec 06
Other Events
12:00am
8-K
fkm8p09
26 Oct 06
Results of Operations and Financial Condition
12:00am
8-K
rnk7mnf3 fysa
10 Oct 06
Theravance Announces Additional Results From Successful Phase 3 Telavancin Complicated Skin and Skin Structure Program
12:00am
8-K
xo3e5t2iidi11qxbcfwn
22 Aug 06
Theravance Announces Positive Results In Phase 3 Telavancin Complicated Skin and Skin Structure Infection Program
12:00am
8-K
wn7meh p4468z7
27 Jul 06
Results of Operations and Financial Condition
12:00am
8-K
zqciy3qkhpverjcetleu
18 Jul 06
Entry into a Material Definitive Agreement
12:00am
8-K
y6u8 0dfi7mcz0y7k
12 May 06
Entry into a Material Definitive Agreement
12:00am
8-K
5l8nzl53i4m5 ff6r
2 May 06
Entry into a Material Definitive Agreement
12:00am
8-K
opj7qv 90xzfxv0
27 Apr 06
Results of Operations and Financial Condition
12:00am
8-K
otyw4ep 5wfi31
10 Feb 06
Departure of Directors or Principal Officers
12:00am
8-K
oq6udboq
9 Feb 06
Results of Operations and Financial Condition
12:00am
8-K
bgqjt9r
3 Feb 06
Entry into a Material Definitive Agreement
12:00am
8-K
xmdarbodzint5gui7c
30 Jan 06
Regulation FD Disclosure
12:00am
8-K
efrgwdew
11 Jan 06
LABA Update Conference Call
12:00am
8-K
5terkha2v7wyzfxt
11 Jan 06
Theravance Updates Guidance for Initiation of Phase 2b in the LABA Collaboration
12:00am
8-K
lfl7bs
12 Dec 05
Departure of Directors or Principal Officers
12:00am
8-K
mc69xn g0
8 Nov 05
Entry into a Material Definitive Agreement
12:00am